nAChR Modulator Explorer Kit

A Screening Package of nAChR Modulators Economically Priced
  • Lyophilized Powder
  • Bioassay Tested
Cat #: EK-202
Sizes: 16 Vials
Last update: 24/04/2019

Alomone Labs is pleased to offer the nAChR Modulator Explorer Kit (#EK-202). This Explorer Kit includes both nAChR blockers and activators, ideal for screening purposes.

For research purposes only, not for human use
Product Name Cat # Size
B-100 1 x 0.5 mg
Chlorpromazine hydrochloride
C-165 1 x 5 g
α-Conotoxin AuIA
STC-960 1 x 0.25 mg
αA-Conotoxin PIVA
STC-600 1 x 50 µg
µ-Conotoxin CnIIIC
STC-640 1 x 50 µg
α-Conotoxin ImI
C-290 1 x 0.1 mg
C-130 1 x 10 mg
DMAB-anabaseine dihydrochloride
D-110 1 x 5 mg
Hexamethonium bromide
H-100 1 x 10 g
(-)-Lobeline hydrochloride
L-120 1 x 100 mg
Mecamylamine hydrochloride
M-105 1 x 5 mg
(-)-Nicotine ditartrate
N-175 1 x 1 g
Pancuronium bromide
P-130 1 x 25 mg
PNU 282987
P-110 1 x 5 mg
RJR 2403 oxalate
R-115 1 x 5 mg
Varenicline tartrate
V-105 1 x 5 mg
Scientific Background

Acetylcholine, released by cholinergic neurons, activates two groups of acetylcholine receptors (AChRs); muscarinic AChRs (mAChRs) which belong to the superfamily of G-protein coupled receptors (GPCRs) and nicotinic AChRs (nAChRs) which belong to the ligand-gated ion channel superfamily. nAChRs also respond to nicotine, hence their name1.

To date, 17 different but related subunits of nAChRs have been identified and cloned. They consist of α subunits (α1-10), which is responsible for the binding of ligands. In fact, this subunit includes a Cys-loop in the first extracellular domain that is required for agonist binding2. The other subunits responsible for making up the active receptor are the β (β1-4), γ, δ and ε subunits3. Structurally, all subunits have the following: a conserved large extracellular N-terminal domain, 3 conserved transmembrane domains, a variable cytoplasmic loop and a fourth transmembrane domain with a short extracellular C-terminal domain.  An active nAChR is generally a heteropentamer of these various subunits organized around a central pore1.

nAChRs are validated therapeutic targets for various CNS pathologies4.

  1. Kombo, D.C. et al. (2011) Eur. J. Med. Chem. In Press.
  2. Albuquerque, E. X. et al. (2009) Physiol. Rev. 89, 73.
  3. Kalamida, D. et al. (2007) FEBS J. 274, 3799.
  4. Karlin, A. et al. (1986) Ann. NY. Acad. Sci. 463, 53.
Related Products